newsfilter
← Latest News
GlobeNewswire·

Viela Bio Announces Pricing of Initial Public Offering

GAITHERSBURG, Md., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Viela Bio, Inc., a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, today announced...